DD128659A5 - Verfahren zur herstellung von 4-androsten-3-onen - Google Patents

Verfahren zur herstellung von 4-androsten-3-onen

Info

Publication number
DD128659A5
DD128659A5 DD7700197658A DD19765877A DD128659A5 DD 128659 A5 DD128659 A5 DD 128659A5 DD 7700197658 A DD7700197658 A DD 7700197658A DD 19765877 A DD19765877 A DD 19765877A DD 128659 A5 DD128659 A5 DD 128659A5
Authority
DD
German Democratic Republic
Prior art keywords
onen
androst
preparation
Prior art date
Application number
DD7700197658A
Other languages
English (en)
Inventor
Rainer Philippson
Bernhard Krieger
Jorge Casals-Stenzel
Ulrich Kerb
Wolfgang Losert
Klaus Prezewowsky
Rudolf Wiechert
Dieter Bittler
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19762609694 external-priority patent/DE2609694C3/de
Priority claimed from DE19762609695 external-priority patent/DE2609695A1/de
Priority claimed from DE19762627186 external-priority patent/DE2627186A1/de
Priority claimed from DE19762627187 external-priority patent/DE2627187A1/de
Priority claimed from DE19762644427 external-priority patent/DE2644427A1/de
Priority claimed from DE19762646043 external-priority patent/DE2646043C2/de
Application filed by Schering Ag filed Critical Schering Ag
Publication of DD128659A5 publication Critical patent/DD128659A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0081—Substituted in position 17 alfa and 17 beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/003—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring the S atom directly linked to a ring carbon atom of the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0038—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 with an androstane skeleton, including 18- or 19-substituted derivatives, 18-nor derivatives and also derivatives where position 17-beta is substituted by a carbon atom not directly bonded to a further carbon atom and not being part of an amide group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • C07J53/004—3 membered carbocyclic rings
    • C07J53/007—3 membered carbocyclic rings in position 6-7
DD7700197658A 1976-03-05 1977-03-03 Verfahren zur herstellung von 4-androsten-3-onen DD128659A5 (de)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
DE19762609694 DE2609694C3 (de) 1976-03-05 1976-03-05 17 a-(3-Hydroxpropyl)-17 ß- hydroxy-7 a-thioalkanoyl-4-androsten- 3-one und Verfahren zu deren Herstellung
DE19762609695 DE2609695A1 (de) 1976-03-05 1976-03-05 7-substituierte 4-androsten-3-one und verfahren zu ihrer herstellung
DE19762627186 DE2627186A1 (de) 1976-03-05 1976-06-16 7-substituierte 4-androsten-3-one und verfahren zu ihrer herstellung iii
DE19762627187 DE2627187A1 (de) 1976-06-16 1976-06-16 7-substituierte 4-androsten-3-one und verfahren zu ihrer herstellung ii
DE19762644427 DE2644427A1 (de) 1976-09-30 1976-09-30 17 beta-hydroxy-17 alpha-(3-acyloxypropyl)-4.6-androstadien-3-one und deren salze
DE19762646043 DE2646043C2 (de) 1976-10-08 1976-10-08 7α-Acetylthio-6α-methyl-4-androsten-3-one, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
DD128659A5 true DD128659A5 (de) 1977-11-30

Family

ID=27544260

Family Applications (1)

Application Number Title Priority Date Filing Date
DD7700197658A DD128659A5 (de) 1976-03-05 1977-03-03 Verfahren zur herstellung von 4-androsten-3-onen

Country Status (15)

Country Link
US (1) US4118488A (de)
JP (1) JPS52111552A (de)
AT (2) AT365611B (de)
BE (1) BE852089A (de)
CA (1) CA1078826A (de)
CH (1) CH631462A5 (de)
DD (1) DD128659A5 (de)
DK (1) DK146856C (de)
FR (1) FR2342990A1 (de)
GB (1) GB1579298A (de)
IE (1) IE44711B1 (de)
IL (1) IL51586A (de)
LU (1) LU76883A1 (de)
NL (1) NL7702369A (de)
SE (1) SE420732B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53116361A (en) * 1977-03-17 1978-10-11 Mitsubishi Chem Ind Ltd Preparation of 7 acylthioo44enee33oxosteroid
ES469510A1 (es) * 1977-05-16 1978-12-01 Schering Ag Procedimiento para la preparacion de 17beta hidroxi-4-an- drosten-3-onas.
DE3111951A1 (de) * 1981-03-23 1982-09-30 Schering Ag, 1000 Berlin Und 4619 Bergkamen 7(alpha)-alkoxycarbonyl-15ss-methylen-4-androstene, verfahren zu ihrer herstellung und verwendung als arzneimittel
DE3130644A1 (de) * 1981-07-29 1983-02-17 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue androstan-derivate, verfahren zu ihrer herstellung und pharmazeutische praeparate, die diese verbindungen enthalten
EP0116974B1 (de) * 1983-02-18 1986-10-29 Schering Aktiengesellschaft 11-Beta-Aryl-Estradiene, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Präparate
US4552871A (en) * 1983-04-13 1985-11-12 Ciba Geigy Corporation Steroids of the 20-spiroxane series, processes for the manufacture thereof, pharmaceutical preparations containing such compounds and the use of the latter
US5981744A (en) * 1995-12-11 1999-11-09 G. D. Searle And Co. Processes for preparation of 9,11-epoxy steroids and intermediates useful therein
DK0944644T3 (da) 1996-12-11 2003-02-03 Searle & Co Fremgangsmåde til fremstilling af 3-keto-7-alfa-alkoxycarbonyl-delta-4,5-steroider og mellemprodukter, som er nyttite derfor
US6887991B1 (en) 1996-12-11 2005-05-03 G. D. Searle & Company Processes for preparation of 9, 11-epoxy steroids and intermediates useful therein
US20030083231A1 (en) * 1998-11-24 2003-05-01 Ahlem Clarence N. Blood cell deficiency treatment method
US7235655B2 (en) * 2002-03-22 2007-06-26 Pharmacia & Upjohn Company Processes to prepare eplerenone
RS90504A (en) * 2002-03-22 2006-10-27 Pharmacia Corporation C-17 spirolactonization and 6,7 oxidation of steroids

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3137690A (en) * 1963-09-26 1964-06-16 Searle & Co 17beta-hydroxy-3-oxoandrost-4-en-17alpha-ylpropionaldehyde lactol and delta1, delta6, delta1, 6, 19-nor and 7alpha-acetylthio congeners
DE1250818B (de) * 1963-10-01 1967-09-28 G. D. Searle & Co., Chicago, 111. (V. St. A.) Verfahren zur Herstellung von 3-Oxozl4.Asteroiden
US3798213A (en) * 1971-01-25 1974-03-19 Merck & Co Inc 7 alpha-methyl-20-spiroxane-3-ones and process
US3753979A (en) * 1971-12-06 1973-08-21 Merck & Co Inc Substituted 1,2alpha-methylene-6,7alpha-halomethylene-20-spirox-4-en-3-ones or 3-ols and acyl esters thereof
DE2251476A1 (de) * 1972-10-20 1974-05-02 Hoechst Ag Verfahren zur herstellung von beta(3-keto-7 alpha-thioacyl-17 beta-hydroxy4-androsten-17 alpha -yl)-propionsaeuregamma -lactonen
CH609357A5 (de) * 1973-05-25 1979-02-28 Schering Ag

Also Published As

Publication number Publication date
AT370110B (de) 1983-03-10
DK146856C (da) 1984-07-02
IL51586A (en) 1981-10-30
GB1579298A (en) 1980-11-19
CA1078826A (en) 1980-06-03
NL7702369A (nl) 1977-09-07
LU76883A1 (de) 1977-07-11
DK96177A (da) 1977-09-06
FR2342990B1 (de) 1979-03-09
IE44711L (en) 1977-09-05
BE852089A (fr) 1977-09-05
ATA141377A (de) 1981-06-15
JPS52111552A (en) 1977-09-19
IE44711B1 (en) 1982-03-10
ATA180980A (de) 1982-07-15
US4118488A (en) 1978-10-03
CH631462A5 (de) 1982-08-13
SE7702455L (sv) 1977-09-06
DK146856B (da) 1984-01-23
SE420732B (sv) 1981-10-26
AT365611B (de) 1982-02-10
FR2342990A1 (fr) 1977-09-30
IL51586A0 (en) 1977-05-31

Similar Documents

Publication Publication Date Title
DD133680A5 (de) Verfahren zur herstellung von polyaetherpolyolen
DD132015A5 (de) Verfahren zur herstellung von trans-hexahydro-pyrido-indolen
DD128672A5 (de) Verfahren zur herstellung von m-aryloxybenzaldehyden
AT348995B (de) Verfahren zur herstellung von acylcyaniden
DD129777A5 (de) Verfahren zur herstellung von phenoxypropionsaeurederivaten
DD128659A5 (de) Verfahren zur herstellung von 4-androsten-3-onen
AT347926B (de) Verfahren zur herstellung von acylcyaniden
DD129903A5 (de) Verfahren zur herstellung von benzoylcyanid
DD131018A5 (de) Verfahren zur herstellung von 2-chlorsulfinylazetidin-4-onen
DD132429A5 (de) Verfahren zur herstellung von derivaten von phenoxyalkansaeuren
DD133795A5 (de) Verfahren zur herstellung von 4a-aryloctahydro-1h-2-pyrindinen
DD132013A5 (de) Verfahren zur herstellung von benzoylcyanid
AT348509B (de) Verfahren zur herstellung von acylcyaniden
ATA706577A (de) Verfahren zur herstellung von substituierten 1-carbamoyl-2-cyanaziridinen
DD131026A5 (de) Verfahren zur herstellung von methyldichlorphosphan
PT67048A (de) Verfahren zur herstellung von 1-amino-2-hydroxy-3-heterocyclyloxy-propanen
DD130241A5 (de) Verfahren zur herstellung von benzoylcyanid
DD128953A1 (de) Verfahren zur herstellung von alkalizellulose
DD128591A5 (de) Verfahren zur herstellung von 2-oxo-1-pyrrolidinen
DD129915A5 (de) Verfahren zur herstellung von 7-alkoxy-3-chlormethyl-3-cephemen
DD129782A5 (de) Verfahren zur herstellung von cholecystokinin-pancreozymin-octapeptidamid-sulfatester
DD129785A5 (de) Verfahren zur herstellung von indazolderivaten
DD129980A5 (de) Verfahren zur herstellung von trans-dihydroindolen
DD129792A5 (de) Verfahren zur herstellung von 1-oxadethiacephalosporinen
DD130785A1 (de) Verfahren zur herstellung von 4-chlor-5-alkoxycarbonyl-2-methoxypyrimidinen